Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mucinex vs IR Guaifenesin in Acute URTI
NCT01537081Phase 3Completed
- Sponsor
- Reckitt
- Start
- Sep 2011
- Primary completion
- Mar 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of acetaminophen in acute upper respiratory tract infection (URI) (3 arms), sponsored by Reckitt. Primary endpoint: Summary Scores on the SUM8 Daily Cough and Phlegm Diary Card at Day 5. Started Sep 2011; status: completed.
02
Drugs
acetaminophen
03
Conditions
acute upper respiratory tract infection (URI)
Beyond the preview
Go deeper on NCT01537081.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01537081.